marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
NeuroBo Pharmaceuticals Income Statement 2011-2024 | NRBO
Annual Income Statement NeuroBo Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
20.7 M | 212 K | 802 K | 84.1 M | 44.5 M | 13.7 M | 106 M | 60.2 M | - | - | - | - | - |
Shares |
5.07 M | 322 K | 771 K | 16.4 M | 5.22 M | 552 K | 414 K | 232 K | - | - | - | - | - |
Historical Prices |
4.09 | 0.66 | 1.04 | 5.12 | 9.1 | 26.8 | 246 | 275 | - | - | - | - | - |
Net Income |
-12.5 M | -14 M | -15.3 M | -29.7 M | -21.3 M | -23.6 M | -33.4 M | -14.6 M | -9.03 M | -320 K | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-15.9 M | -19.6 M | -15.3 M | -29.7 M | -20.2 M | -15.5 M | -33.1 M | -14.7 M | -8.08 M | -266 K | - | - | - |
Interest Expense |
3.42 M | 5.66 M | 14 K | -1 K | -22 K | -3 K | -5 K | -4 K | 7 K | 1 K | - | - | - |
EBITDA |
-15.9 M | -19.6 M | -15.2 M | -29.7 M | -20.2 M | -22.8 M | -33.1 M | -14.7 M | -6.07 M | -267 K | - | - | - |
Operating Expenses |
- | - | - | 29.7 M | 20.2 M | 22.8 M | 33.1 M | 14.7 M | - | - | - | - | - |
General and Administrative Expenses |
6.73 M | 8.64 M | 8.75 M | 7.85 M | 2.7 M | 8.49 M | - | 5.96 M | 3.18 M | 214 K | - | - | - |
All numbers in USD currency
Quarterly Income Statement NeuroBo Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
10.2 M | 5.43 M | 4.91 M | 5.08 M | 5.06 M | 40.5 M | 25.4 M | 889 K | 889 K | 889 K | 889 K | 743 K | 22 M | 21.6 M | 19.7 M | 16.4 M | 16.3 M | 15.7 M | 15.6 M | 5.17 M | 5.17 M | 5.17 M | 5.17 M | 14.3 M | 14.2 M | 12.4 M | 10.6 M | 10.6 M | 10.6 M | 9.52 M | 9.27 M | 6.98 M | 3.63 M | 3.47 M | 3.76 M | 2.73 M | 2.95 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-5.65 M | -10.1 M | - | -3.82 M | -734 K | -2.6 M | - | -3.11 M | -3.3 M | -2.88 M | - | -3.46 M | -3.92 M | -3.32 M | - | -3.05 M | -2.38 M | -4.73 M | - | -3.62 M | -1.9 M | -2.46 M | -3.66 M | -6.08 M | -6.68 M | -7.22 M | -6.75 M | -8.67 M | -10.5 M | -7.5 M | -7.21 M | -3.88 M | -1.39 M | -2.1 M | -2.57 M | -2.57 M | -1.61 M | -2.28 M | -196 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-6.26 M | -10.1 M | - | -3.89 M | -3.81 M | -2.52 M | - | -3.1 M | -3.22 M | -2.88 M | - | -3.46 M | -3.93 M | -3.33 M | - | -3.06 M | -2.39 M | -4.75 M | - | -3.64 M | -1.89 M | -2.45 M | -3.3 M | -5.91 M | -6.53 M | -7.06 M | -6.57 M | -8.54 M | -10.5 M | -7.5 M | -7.23 M | -3.4 M | -1.84 M | -2.23 M | -2.51 M | -2.37 M | -1.61 M | -1.59 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
607 K | 31 K | - | 75 K | 3.07 M | - | - | - | - | - | - | 3 K | 5 K | 6 K | - | -1 K | -1 K | -1 K | - | -1.12 M | -581 K | -171 K | -177 K | -1 K | -144 K | -160 K | -179 K | -5 K | -5 K | -5 K | 1 K | -1 K | -4 K | -4 K | 2 K | 6 K | -1 K | -690 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-6.25 M | - | - | -3.89 M | - | -2.52 M | - | -3.08 M | -3.2 M | -2.86 M | - | -3.43 M | -3.9 M | -3.32 M | - | -3.05 M | -2.38 M | -4.74 M | - | -3.64 M | -1.89 M | -2.45 M | -3.3 M | -5.91 M | -6.53 M | -7.06 M | -6.57 M | -8.54 M | -10.5 M | -7.5 M | -7.23 M | -3.4 M | -1.84 M | -2.23 M | -2.51 M | -2.37 M | -1.61 M | -1.59 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.84 M | - | - | - | 1.61 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
1.74 M | 2.01 M | - | 1.6 M | 1.44 M | 1.88 M | - | 2.53 M | 2.24 M | 1.96 M | - | 2.07 M | 1.91 M | 2.19 M | - | 1.8 M | 1.72 M | 2.6 M | - | 2.5 M | 939 K | 651 K | 1.47 M | 2.36 M | 2.57 M | 2.09 M | 1.49 M | 2.05 M | 4.68 M | 2.22 M | 2.39 M | 1.47 M | 1.05 M | 1.05 M | 1.05 M | 997 K | 658 K | 475 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency